Alzamend Neuro Inc (NASDAQ:ALZN)’s traded shares stood at 0.28 million during the last session, with the company’s beta value hitting -0.28. At the close of
Alzamend Neuro Inc (NASDAQ:ALZN) has a beta value of -0.14 and has seen 2.01 million shares traded in the last trading session. The company, currently
During the recent session, Alzamend Neuro Inc (NASDAQ:ALZN)’s traded shares were 56.82 million, with the beta value of the company hitting -0.31. At the last
Alzamend Neuro Inc (NASDAQ:ALZN) has a beta value of -0.17 and has seen 5.77 million shares traded in the last trading session. The company, currently
During the last session, Alzamend Neuro Inc (NASDAQ:ALZN)’s traded shares were 0.32 million, with the beta value of the company hitting -0.17. At the end
In today’s recent session, 0.64 million shares of the Alzamend Neuro Inc (NASDAQ:ALZN) have been traded, and its beta is -0.17. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne